Relay Therapeutics (RLAY) Gains from Investment Securities (2019 - 2025)
Relay Therapeutics (RLAY) reported Gains from Investment Securities of -$35000.0 for Q4 2025, up 99.56% quarter-over-quarter from -$7.9 million in Q3 2025.
Relay Therapeutics (RLAY) Gains from Investment Securities (2019 - 2025) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of Gains from Investment Securities data on file, last reported at -$35000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$35000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$12.5 million (changed N/A YoY), and the FY2025 annual result was $3.0 million, changed N/A from the prior year.
- Gains from Investment Securities rose to -$35000.0 in Q4 2025 per RLAY's latest filing, from -$7.9 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.5 million in Q1 2023 and troughed at -$7.9 million in Q3 2025.
- A 4-year average of -$656840.0 and a median of $1.4 million in 2021 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities plunged 38.16% in 2021, then jumped 132.92% in 2023.
- A 4-year view of Gains from Investment Securities shows it stood at $1.2 million in 2021, then tumbled by 482.92% to -$4.6 million in 2022, then jumped by 132.92% to $1.5 million in 2023, then tumbled by 102.31% to -$35000.0 in 2025.
- Business Quant data shows RLAY's Gains from Investment Securities at -$35000.0 in Q4 2025, -$7.9 million in Q3 2025, and $1.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | -7.88 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.51 Mn |
| Mar 31, 2022 | -4.60 Mn |
| Mar 31, 2022 | -4.60 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Dec 31, 2019 | 5.31 Mn |
| Dec 31, 2019 | 5.31 Mn |